# Verapamil Hydrochloride

NDC: 0591-2882
Generic name: verapamil hydrochloride
Labeler / Manufacturer: Teva Pharmaceuticals Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, DELAYED RELEASE PELLETS
Routes: ORAL
Marketing started: 19900529
Marketing ended: 20260731
FDA application: NDA019614

## Active ingredients

- VERAPAMIL HYDROCHLORIDE: 180 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0591-2882"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0591-2882
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0742cf97-601b-4c13-a6c3-1a6a616ed292